Supplier News

Jan 04, 2018
By BioPharm International Editors
The contract manufacturing company has completed construction on a new aseptic fill/finish facility in Wuxi, China.
Jan 04, 2018
By BioPharm International Editors
The companies will collaborate on the development of vaccines to expand GeoVax’s cancer immunotherapy program.
Dec 28, 2017
By BioPharm International Editors
The biotechnology company has filed for FDA approval of a new plasma manufacturing facility in Covington, GA, to support its immunology franchise.
Dec 28, 2017
By BioPharm International Editors
The companies have entered an agreement involving assay development and the manufacturing of kits supporting biomarker research programs.
Dec 20, 2017
By BioPharm International Editors
MilliporeSigma will collaborate with IPS and G-CON to offer end-to-end, turnkey, modular MAb manufacturing.
Dec 19, 2017
By BioPharm International Editors
The company has completed development of a first-generation production process for its chimeric antigen receptor regulatory T cell product portfolio and is selecting a CMO for clinical supply.
Dec 19, 2017
By BioPharm International Editors
BioTek Instruments has released a second edition of its BioSpa software that now offers users a simplified but effective interface for kinetic imaging or detection workflows.
Dec 14, 2017
By BioPharm International Editors
Abzena has entered into a Master Services Agreement with a US biotech company to provide process development and manufacturing services to progress a novel antibody-drug conjugate (ADC) to clinical trials.
Dec 13, 2017
By BioPharm International Editors
The European Medicines Agency has granted Samsung BioLogics approval to manufacture a monoclonal antibody at the company’s second facility in Songdo, Incheon, South Korea.
Dec 12, 2017
By BioPharm International Editors
SGS has introduced a Sanger sequencing service at its Glasgow, United Kingdom, laboratory to support genetic stability testing and perform identity testing on cell banks, plasmids, and viral seeds/vectors.
native1_300x100
lorem ipsum